Can visual evoked potentials be used as a fifth site for determination of dissemination in space?
The 2017 McDonald criteria for multiple sclerosis (MS) diagnosis do not include the optic nerve as a site for dissemination in space (DIS). Investigators evaluated performance characteristics of the optic nerve as a fifth region in a clinically isolated syndrome (CIS) cohort. Of 1238 participants, 388 patients <50 years old with CIS were included, 151 of whom had a second clinical event or at least 10 years follow-up. The researchers collected data on brain and spine MRI and on visual evoked potentials (VEPs). VEPs were considered abnormal based on local normative data: P100 wave latency >112 milliseconds, >8 milliseconds inter-eye latency, or absence of P100 wave. MS was confirmed by a second clinical attack.
Among all 1238 patients, VEPs w…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)